Eurand, a specialty pharmaceutical company, has appointed Ruth Thieroff-Ekerdt to the newly created position of chief medical officer, effective December 1, 2008. She will be based in the company's Yardley, Pennsylvania, office.
Subscribe to our email newsletter
Dr Thieroff-Ekerdt will have full responsibility for managing Eurand’s clinical R&D, medical and regulatory affairs, and drug safety and surveillance activities.
Before joining Eurand, Dr Thieroff-Ekerdt was vice president of global clinical and medical affairs for Bayer Consumer Care, with responsibility for clinical development, clinical operations, medical affairs and pharmacovigilance for consumer care products worldwide. Her experience also includes positions of increasing scope and responsibility at the Berlex division of Schering.
Gearoid Faherty, chairman and CEO of Eurand, said: “We look forward to benefiting from her expertise, leadership skills and wide range of experience in all phases of drug development.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.